Showing results (601-610 of 635) with videos related to

Sort By:
Pageof 64
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2021
Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION studyPaolo Ventura, Herbert L Bonkovsky, Laurent Gouya, et al.
Brachytherapy|August 20, 2013
Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patientsJennifer L Peterson, Laura A Vallow, Douglas W Johnson, et al.
BJU International|July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapyRichard J Lee, Katherine S Tzou, Michael G Heckman, et al.
Transplantation Proceedings|September 19, 2006
Single-center experience of pediatric heart transplantation in taiwanN K Chou, C H Chang, N H Chi, et al.
Current Oncology (Toronto, Ont.)|February 14, 2014
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statementP J Karanicolas, P Metrakos, K Chan, et al.
Oncogene|October 15, 2013
HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptaseC-H Tsai, C-H Teng, Y-T Tu, et al.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 30, 2021
Care transitions and social needs: A Geriatric Emergency care Applied Research (GEAR) Network scoping review and consensus statementCameron J Gettel, Corrine I Voils, Alycia A Bristol, et al.
Oncogene|April 4, 2017
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasisC-J Ko, S-W Lan, Y-C Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancerB M Wolpin, E M O'Reilly, Y J Ko, et al.
Pageof 64